Nemaura Medical, Inc. Common Stock (NMRD)

NMRD was delisted on the 4th of January, 2024.

• Market cap: $3.04M
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.

Employees: 38